Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Alyria is a medical-grade skincare company that focuses on developing advanced dermatological products for aesthetic and therapeutic use. The company's product line is formulated with high concentrations of active ingredients such as retinol, glycolic acid, and peptides to address various skin concerns including aging, hyperpigmentation, and acne. Alyria's products are primarily distributed through dermatologists, plastic surgeons, and medical spas, positioning the brand within the professional physician-dispensed skincare market. The company emphasizes clinical efficacy and scientific formulation to provide visible results for patients undergoing aesthetic procedures or seeking intensive skin health management.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Alyria.